Anti-microbial action against verotoxigenic Escherichia coli O157:H7 of nitric oxide derived from sodium nitrite.
The levels of verotoxin-1 and verotoxin-2 released by verotoxigenic Escherichia coli O157:H7 treated in vitro with sodium nitrite, sodium chloride and several antibiotics were evaluated. Of the three strains of E. coli O157:H7 used in this study, two strains produced both verotoxin-1 and verotoxin-2, and one strain produced only verotoxin-2. Treatment of E. coli O157:H7 with sodium nitrite (6000 mg/l, minimum inhibitory concentration) did not increase the levels of verotoxin-1 and verotoxin-2 compared with a treatment by sodium chloride or antibiotics. When the electron paramagnetic resonance spectrum of sodium nitrite-treated bacterial cells was examined at 77 K to clarify the mechanism for the anti-bacterial activity of nitric oxide derived from sodium nitrite, electron paramagnetic resonance signals with g-values of 2.035 and 2.010 were observed. These were identified as being derived from iron-nitric oxide complexes. It appears that the dinitrosyl iron complexes in the E. coli O157:H7 cells were generated from the reaction of iron-sulfur proteins (enzymes) with nitric oxide formed by the reduction of sodium nitrite. The amount of ATP was decreased by the presence of sodium nitrite in the cell suspension. These findings indicate that nitric oxide derived from sodium nitrite penetrated the cells and inactivated enzymes related to the respiratory chain.
Morita
Hidetoshi
H
School of Veterinary Medicine, Azabu University, Sagamihara, Japan. morita@azabu-u.ac.jp
Yoshikawa
Hiroshi
H
Suzuki
Takehito
T
Hisamatsu
Shin
S
Kato
Yukio
Y
Sakata
Ryoichi
R
Nagata
Yukiharu
Y
Yoshimura
Tetsuhiko
T
D000255:Adenosine Triphosphate / Q000378:metabolism; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D004578:Electron Spin Resonance Spectroscopy; D019453:Escherichia coli O157 / Q000187:drug effects* / Q000378:metabolism; D009569:Nitric Oxide / Q000378:metabolism*; D022622:Shiga Toxin 1 / Q000378:metabolism*; D022641:Shiga Toxin 2 / Q000378:metabolism*; D012965:Sodium Chloride / Q000494:pharmacology; D012977:Sodium Nitrite / Q000494:pharmacology*
D000900:Anti-Bacterial Agents; D022622:Shiga Toxin 1; D022641:Shiga Toxin 2; D009569:Nitric Oxide; D012965:Sodium Chloride; D000255:Adenosine Triphosphate; D012977:Sodium Nitrite